Concepedia

Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma

Anouk E.J. Latenstein, Lydia G. van der Geest, Bert A. Bonsing, Bas Groot Koerkamp, Nadia Haj Mohammad, Ignace H. J. T. de Hingh, Vincent E. de Meijer, I. Quintus Molenaar, Hjalmar C. van Santvoort, Geertjan van Tienhoven,

European Journal of Cancer · 2019 · 160 citations · 33 references

DOIFull text

Open access

References

33

Cancer statistics, 2017

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 14.9K citations · Full text

, , +21

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm, Douglas G. Altman, Matthias Egger et al. · BMJ · 2007 · 9.2K citations · Full text

, , +17

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.6K citations · Full text

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.5K citations

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text